Condition: Acute Lower Limb Arterial Occlusion · Sponsor: Inari Medical
This study is a post-market, prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the Artix Thrombectomy System in patients with acute lower extremity arterial occlusions.
This description comes directly from the study's public registry record.
James Allen · 651-279-8587 · james.allen2@stryker.com
Chris Ottaviano · 609-634-4571 · chris.ottaviano@stryker.com
Always discuss trial participation with your own doctor first.
| Yale University | New Haven, Connecticut, United States | Recruiting |
| MedStar Washington Hospital Center | Washington D.C., District of Columbia, United States | Recruiting |
| Ascension Sacred Heart Pensacola | Pensacola, Florida, United States | Recruiting |
| Terrebonne General Hospital/Cardiovascular Institute of the South | Houma, Louisiana, United States | Recruiting |
| Mass General Hospital | Boston, Massachusetts, United States | Recruiting |
| MyMichigan Health | Midland, Michigan, United States | Recruiting |
| Cooper University Hospital | Camden, New Jersey, United States | Recruiting |
| Mission Memorial Hospital | Asheville, North Carolina, United States | Recruiting |
| Aultman Hospital | Canton, Ohio, United States | Recruiting |
| The Christ Hospital | Cincinnati, Ohio, United States | Recruiting |
| Ascension St. John Jane Phillips Medical Center | Bartlesville, Oklahoma, United States | Recruiting |
| Saint Francis Hospital | Tulsa, Oklahoma, United States | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07135895